Back to SYRE

Candriam S.C.A. → SYRE

Candriam S.C.A. SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
6
Latest value
$40.1M
Q3 2026
Peak value
$48.5M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$6.8M
Q4 2025$13.9M
Q4 2025$13.9M
Q1 2026$30.8M
Q2 2026$48.5M
Q3 2026$40.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$40.1M448.6K——
Q2 2026$48.5M546.3K——
Q1 2026$30.8M610.3K——
Q4 2025$13.9M425.5K——
Q4 2025$13.9M425.5K——
Q3 2025$6.8M404.4K——

Other funds holding SYRE

Other Candriam S.C.A. positions

NVDA

NVIDIA CORPORATION

$1.6B
NVDA

NVIDIA CORPORATION

$1.4B
MSFT

MICROSOFT CORP

$1.3B
MSFT

MICROSOFT CORP

$1.3B
NVDA

NVIDIA CORPORATION

$1.3B
NVDA

NVIDIA CORPORATION

$1.3B
NVDA

NVIDIA CORPORATION

$1.3B
MSFT

MICROSOFT CORP

$1.3B